SE409286B - Sett att framstella en fast, terapeutisk beredning for oralt bruk - Google Patents

Sett att framstella en fast, terapeutisk beredning for oralt bruk

Info

Publication number
SE409286B
SE409286B SE7502725A SE7502725A SE409286B SE 409286 B SE409286 B SE 409286B SE 7502725 A SE7502725 A SE 7502725A SE 7502725 A SE7502725 A SE 7502725A SE 409286 B SE409286 B SE 409286B
Authority
SE
Sweden
Prior art keywords
prepare
way
oral use
therapeutic preparation
fixed therapeutic
Prior art date
Application number
SE7502725A
Other languages
English (en)
Swedish (sv)
Other versions
SE7502725L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
S Watanabe
M Kayano
Y Ishino
K Miyao
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of SE7502725L publication Critical patent/SE7502725L/
Publication of SE409286B publication Critical patent/SE409286B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
SE7502725A 1974-03-12 1975-03-11 Sett att framstella en fast, terapeutisk beredning for oralt bruk SE409286B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-03-12 1974-03-12

Publications (2)

Publication Number Publication Date
SE7502725L SE7502725L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-09-15
SE409286B true SE409286B (sv) 1979-08-13

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7502725A SE409286B (sv) 1974-03-12 1975-03-11 Sett att framstella en fast, terapeutisk beredning for oralt bruk

Country Status (12)

Country Link
US (1) US3976764A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5512411B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE826498A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1054056A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH604719A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2510620C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK142802B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES435500A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2263744B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1507521A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7502952A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE409286B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
ATE34300T1 (de) * 1981-07-15 1988-06-15 Key Pharma Theophyllin mit verlaengerter abgabe.
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS5953410A (ja) * 1982-09-20 1984-03-28 Fujisawa Pharmaceut Co Ltd 新型ソフトカプセル剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
JPS61107782U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1984-12-19 1986-07-08
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
CA2085585A1 (en) * 1990-06-25 1991-12-26 George Torosian Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
KR100620935B1 (ko) 1998-03-19 2006-09-13 브리스톨-마이어스스퀴브컴파니 용해도가 높은 약물에 대한 2상 서방성 전달 시스템과 방법
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
PL213804B1 (pl) * 2003-02-21 2013-05-31 Lek Pharmaceuticals Uklad terapeutyczny do podawania amoksycyliny i kwasu klawulanowego, oraz kapsulka unoszaca sie na powierzchni cieczy
CA2536040A1 (en) * 2003-11-04 2005-05-26 Shire Laboratories Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
BRPI0716481A2 (pt) * 2006-09-04 2014-03-18 Panacea Biotec Ltd Tecnologia de liberação flutuante programável
WO2009087665A2 (en) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Novel gastroretentive drug delivery system
GB2462022B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
JP2012500230A (ja) * 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
EP2457561A4 (en) * 2009-07-06 2014-03-05 Kyorin Seiyaku Kk TABLET WITH HIGH STRUCTURE
AU2011275881B2 (en) * 2010-07-05 2014-11-06 Jagotec Ag Dosage form
US20140234409A1 (en) * 2011-07-14 2014-08-21 APET Holding B.V. Nicotinamide compositions and the therapeutic use thereof
US10137094B2 (en) 2011-10-11 2018-11-27 Sun Pharmaceutical Industries Limited Gastroretentive dosage system and process of preparation thereof
MX2015000760A (es) * 2012-07-16 2015-09-10 Apet Holding B V Sistema de suministro de farmaco gastro - retentivo.
HUE025008T2 (en) 2012-10-12 2016-04-28 Omya Int Ag Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
CN106714893B (zh) 2014-06-11 2021-01-01 麻省理工学院 自组装的驻留装置及相关方法
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
CA2983272C (en) 2015-05-01 2023-08-29 Massachusetts Institute Of Technology Triggerable shape memory induction devices
CA3002916C (en) 2015-10-23 2024-06-11 Lyndra, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
SG11201804384UA (en) 2015-12-08 2018-06-28 Lyndra Inc Geometric configurations for gastric residence systems
WO2017158171A1 (en) * 2016-03-18 2017-09-21 Grünenthal GmbH Floating pharmaceutical dosage form
CN109310639A (zh) 2016-05-27 2019-02-05 林德拉有限公司 用于胃驻留系统的材料结构
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
US11576866B2 (en) 2016-09-30 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
WO2018227147A1 (en) 2017-06-09 2018-12-13 Lyndra, Inc. Gastric residence systems with release rate-modulating films
JP7525935B2 (ja) * 2020-03-02 2024-07-31 クラフト ヘルス プライベート リミテッド 持続的薬物放出のための経口剤形の製造方法
EP4008509B1 (de) * 2020-10-14 2023-06-07 Bichsel, Hannes Geschäumte biogranulatkörner
WO2023166225A1 (en) * 2022-03-04 2023-09-07 APET Holding B.V. Digestive enzyme formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Also Published As

Publication number Publication date
FR2263744B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-11-24
DK97875A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-09-13
ES435500A1 (es) 1977-02-01
NL7502952A (nl) 1975-09-16
CH604719A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-09-15
DK142802B (da) 1981-02-02
JPS5512411B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-04-02
US3976764A (en) 1976-08-24
FR2263744A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-10-10
DK142802C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-09-21
SE7502725L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-09-15
CA1054056A (en) 1979-05-08
GB1507521A (en) 1978-04-19
DE2510620C2 (de) 1984-01-05
DE2510620A1 (de) 1975-09-18
JPS50121418A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-09-23
BE826498A (fr) 1975-06-30

Similar Documents

Publication Publication Date Title
SE409286B (sv) Sett att framstella en fast, terapeutisk beredning for oralt bruk
DK349775A (da) Mundplejemiddel
IT1042001B (it) Miglioramenti relativi a laminati
IT1042000B (it) Miglioramenti relativi a laminati
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE7510752L (sv) Galenisk beredning for allopyrinol-langtidsterapi
FR2347026A1 (fr) Piece a main dentaire
SE425312B (sv) Sett att framstella morfolinderivat
IT1044520B (it) Carrozzina per bambini
DK357275A (da) Mundplejemiddel
SE7505595L (sv) Sett att framstella abietamidderivat.
SE427655B (sv) Sett att framstella abietamidderivat
DK433875A (da) Mundplejemiddel
SE427930B (sv) Sett att atervinna organotennhalogenider
DK135483C (da) Tandproteseartikulator
SE418573B (sv) Sett att framstella ett vaccin
SE428471B (sv) Sett att framstella imidazolderivat
SE7508561L (sv) Sett att framstella alfa-azidobensylpenicillin
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat
SE7513234L (sv) Sett att framstella en vanadinkatalysator
SE420722B (sv) Sett att framstella benshydryloxi-alkylaminderivat
SE414634B (sv) Sett att framstella 1-dietylamino-etyl-3(p-metoxibensyl)-1,2-dihydro-kinoxalin-2-on-fumarat
BE826797A (fr) Perfectionnements relatifs a des trepans

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7502725-0

Effective date: 19931008

Format of ref document f/p: F